Ophthalmic Lasers Market Trends, Price, Demands and Forecasts to 2020

According to Stratistics MRC, the Global Ophthalmic Lasers market is accounted for $45.87 billion in 2015 and is expected to reach $63.78 billion by 2022 growing at a CAGR of 4.8%. Development in lasers technology for correcting the vision of people affected with myopia and hyper-myopia and advanced diagnostic technologies such as optical coherence tomography is backing up the market. Increasing geriatric population coupled with increment in the prevalence of eye diseases are the key factors in the advancement of ophthalmic laser devices. The uncertainty in reimbursement structure and poor healthcare infrastructure in developing countries are some of the factors hindering the market.

The photocoagulating ophthalmic lasers segment has accounted for highest market type owing to its varied use in treatment of retinal vascular disorders and myriad retinal conditions. Rise in aging population is to boost the sales of ophthalmic lasers, as they are more susceptible to vision deterioration such as age-related macular degeneration (AMD) applications. North America accounted for highest market share attributed to the increase in geriatric population affected with ocular disorders.

Browse full report with TOC@ https://marketreportscenter.com/reports/415466/ophthalmic-lasers-global-market-outlook-2016-2022

Some of the key players of the Ophthalmic Lasers market include A.R.C. Laser, Abbott Medical Optics, Alcon, Bausch & Lomb Incorporated, Calmar Laser, Carl Zeiss Meditec, Ellex Medical Lasers Limited, IRIDEX, Lumenis Ltd., Meridian, Nidek Co. Ltd., Optos, Quantel, SCHWIND eye-tech-solutions GmbH & Co. KG, Synergetics, Topcon and Ziemer Ophthalmic Systems AG.

Types Covered:

Photocoagulating lasers

o Argon Lasers

o Diode Lasers

Excimer Laser

Krypton Lasers

Photodisrupting lasers

SLT lasers

YAG (yttrium-aluminium-garnet) laser

Applications Covered:

Age related Macular Degeneration

Central Serous Chorioretinopathy

Diabetic...